STIMULATION OF THE OTIC GANGLION FOR TREATING MEDICAL CONDITIONS

• US 20080033509A1
• Filed: 01/29/2007
• Published: 02/07/2008
• Est. Priority Date: 04/25/2002
• Status: Active Grant

• Current Assignee: BrainsGate Ltd.
• Original Assignee: BrainsGate Ltd.
• Inventors: Gross, Yossi, Shalev, Alon
• Granted Patent: US 7,684,859 B2
• Time in Patent Office: Days
• US Class Current: 607/63
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61N 1/32 alternating or intermittent currents applying electric fields by inductive or capacitive coupling A61N1/40; microwave apparatus A61N5/02
• CPC Class Codes: A61N 1/36017 with leads or electrodes penetrating the skin
• CPC Class Codes: A61N 1/36025 for treating a mental or cerebral condition
• CPC Class Codes: A61N 1/36082 Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease

Abstract

Apparatus is provided including one or more electrodes, adapted to be applied to an otic-ganglion site of a patient selected from the group consisting of: an otic ganglion, an associated neural tract of the otic ganglion, an afferent fiber going into the otic ganglion, and an efferent fiber going out of the otic ganglion. The apparatus further includes a stimulator, configured to drive the one or more electrodes to apply a current to the otic-ganglion site, and to configure the current to activate the otic-ganglion site sufficiently to induce at least one effect selected from the group consisting of: a change in cerebral blood flow (CBF) of the patient, and a change in permeability of a blood-brain-barrier (BBB) of the patient. Other embodiments are also described.

Claims

1. Apparatus comprising:

one or more electrodes, adapted to be applied to an otic-ganglion site of a patient selected from the group consisting of;

an otic ganglion, an associated neural tract of the otic ganglion, an afferent fiber going into the otic ganglion, and an efferent fiber going out of the otic ganglion; and

a stimulator, configured to;

drive the one or more electrodes to apply a current to the otic-ganglion site, and

configure the current to activate the otic-ganglion site sufficiently to induce at least one effect selected from the group consisting of;

a change in cerebral blood flow (CBF) of the patient, and a change in permeability of a blood-brain-barrier (BBB) of the patient.

2. The apparatus according to claim 1, wherein the stimulator is configured to configure the current to activate the otic-ganglion site sufficiently to induce an increase in the CBF.

3. The apparatus according to claim 2, wherein the stimulator is configured to configure the current to activate the otic-ganglion site sufficiently to treat stroke of the patient, by inducing the increase in the CBF.

4. The apparatus according to claim 2, wherein the stimulator is configured to configure the current to activate the otic-ganglion site sufficiently to treat a condition of the patient, by inducing the increase in the CBF, the condition selected from the group consisting of:

depression, and anxiety.

5. The apparatus according to claim 1, wherein the stimulator is configured to configure the current to activate the otic-ganglion site sufficiently to induce an increase in BBB permeability.

6. The apparatus according to claim 5, wherein the stimulator is configured to configure the current to activate the otic-ganglion site sufficiently to facilitate drug transport across the BBB, by inducing the increase in BBB permeability.

7. The apparatus according to claim 1, wherein the stimulator is configured to configure the current to control properties of posterior cephalic circulation.

8. The apparatus according to claim 1, wherein the stimulator is configured to drive the one or more electrodes to apply the current on a long-term basis.

9. The apparatus according to claim 1, wherein the otic-ganglion site includes the otic ganglion, wherein the one or more electrodes are adapted to be applied to the otic ganglion, and wherein the stimulator is configured to drive the one or more electrodes to apply the current to the otic ganglion.

10. The apparatus according to claim 1, wherein the otic-ganglion site includes the associated neural tract of the otic ganglion, wherein the one or more electrodes are adapted to be applied to the associated neural tract of the otic ganglion, and wherein the stimulator is configured to drive the one or more electrodes to apply the current to the associated neural tract of the otic ganglion.

11. The apparatus according to claim 1, wherein the otic-ganglion site is selected from the group consisting of:

the afferent fiber going into the otic ganglion, and the efferent fiber going out of the otic ganglion, wherein the one or more electrodes are adapted to be applied to the selected site, and wherein the stimulator is configured to drive the one or more electrodes to apply the current to the selected site.

12. The apparatus according to claim 1, wherein the stimulator is configured to be implanted in a body of the patient.

13. The apparatus according to claim 1, wherein the stimulator comprises circuitry, which comprises:

an implantable unit, configured to be implanted in a body of the patient, the implantable unit comprising an implantable unit coupler; and

an external unit, comprising an external unit coupler configured to be wirelessly coupled to the implantable unit coupler, the external unit configured to convey a control signal from the external unit coupler to the implantable unit coupler, which signal drives the implantable unit to drive the electrodes to apply the current to the site.

14. The apparatus according to claim 1, wherein the one or more electrodes are adapted for a period of implantation in the patient of greater than about one month.

15. The apparatus according to claim 1, wherein the one or more electrodes are adapted for a period of implantation in the patient of less than one week.

16. The apparatus according to claim 1, wherein the stimulator is configured to drive the one or more electrodes by wireless communication from a position external to the patient.

17. The apparatus according to claim 1, wherein the stimulator is configured to configure the current to activate the otic-ganglion site sufficiently to treat a condition of the patient selected from the group consisting of:

a brain tumor, epilepsy, Parkinson'"'"'s disease, Alzheimer'"'"'s disease, multiple sclerosis, schizophrenia, and stress.

18. A method comprising:

selecting an otic-ganglion site of a patient from the group consisting of;

an otic ganglion, an associated neural tract of the otic ganglion, an afferent fiber going into the otic ganglion, and an efferent fiber going out of the otic ganglion; and

applying a current to the otic-ganglion site, and configuring the current to activate the site sufficiently to induce at least one effect selected from the group consisting of;

a change in cerebral blood flow (CBF) of the patient, and a change in permeability of a blood-brain-barrier (BBB) of the patient.

19. The method according to claim 18, comprising identifying that the patient may benefit from the at least one effect, wherein applying the current comprises applying the current responsively to the identifying.

20. The method according to claim 18, wherein configuring the current comprises configuring the current to activate the otic-ganglion site sufficiently to induce an increase in the CBF.

21. The method according to claim 20, wherein configuring the current comprises configuring the current to activate the otic-ganglion site sufficiently to treat stroke of the patient, by inducing the increase in the CBF.

22. The method according to claim 20, wherein configuring the current comprises configuring the current to activate the otic-ganglion site sufficiently to treat a condition of the patient, by inducing the increase in the CBF, the condition selected from the group consisting of:

depression, and anxiety.

23. The method according to claim 18, wherein configuring the current comprises configuring the current to activate the otic-ganglion site sufficiently to induce an increase in BBB permeability.

24. The method according to claim 23, wherein configuring the current comprises configuring the current to activate the otic-ganglion site sufficiently to facilitate drug transport across the BBB, by inducing the increase in BBB permeability.

25. The method according to claim 18, wherein configuring the current comprises configuring the current to control properties of posterior cephalic circulation.

26. The method according to claim 18, wherein applying the current comprises applying the current on a long-term basis.

27. The method according to claim 18, wherein the otic-ganglion site includes the otic ganglion, and wherein applying the current comprises applying the current to the otic ganglion.

28. The method according to claim 18, wherein the otic-ganglion site includes the associated neural tract of the otic ganglion, and wherein applying the current comprises applying the current to the associated neural tract of the otic ganglion.

29. The method according to claim 18, wherein the otic-ganglion site is selected from the group consisting of:

the afferent fiber going into the otic ganglion, and the efferent fiber going out of the otic ganglion, and wherein applying the current comprises applying the current to the selected site.

30. The method according to claim 18, wherein applying the current comprises implanting a stimulator in a body of the patient, and applying the current by the stimulator.

31. The method according to claim 18, wherein applying the current comprises:

wirelessly conveying a control signal from a position external to a body of the patient;

receiving the control signal at a position within the body; and

responsively to the received control signal, applying the current to the site.

32. The method according to claim 18, wherein applying the current comprises implanting one or more electrodes for a period of implantation in the patient of greater than about one month, and driving the one or more electrodes to apply the current.

33. The method according to claim 18, wherein applying the current comprises implanting one or more electrodes for a period of implantation in the patient of less than one week, and driving the one or more electrodes to apply the current.

34. The method according to claim 18, wherein applying the current comprises implanting one or more electrodes, and driving the one or more electrodes, by wireless communication from a position external to the patient, to apply the current to the site.

35. The method according to claim 18, wherein configuring the current comprises configuring the current to activate the otic-ganglion site sufficiently to treat a condition of the patient selected from the group consisting of:

a brain tumor, epilepsy, Parkinson'"'"'s disease, Alzheimer'"'"'s disease, multiple sclerosis, schizophrenia, and stress.